Capauto, Davide
Wang, Yifan
Wu, Feinan
Norton, Scott
Mariani, Jessica
Inoue, Fumitaka
Crawford, Gregory E.
Ahituv, Nadav
Abyzov, Alexej
Vaccarino, Flora M.
Funding for this research was provided by:
National Institute of Mental Health (R56 MH114901)
National Institute of Mental Health (U01 MH116438)
National Institute of Mental Health (R56 MH114899)
National Institute of Mental Health (R01 MH109648)
Simons Foundation (632742)
Article History
Received: 8 September 2023
Accepted: 11 February 2024
First Online: 16 February 2024
Competing interests
: NA is the cofounder and on the scientific advisory board of Regel Therapeutics and receives funding from BioMarin Pharmaceutical Incorporated. All other authors do not hold any competing interest.